I am a
Home I AM A Search Login

Papers of the Week


Papers: 27 Aug 2022 - 2 Sep 2022


2022 Aug 26


Cochrane Database Syst Rev


8

Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use.

Authors

Christelle K, Norhayati MN, Jaafar S H
Cochrane Database Syst Rev. 2022 Aug 26; 8:CD006034.
PMID: 36017945.

Abstract

Heavy menstrual bleeding and pain are common reasons women discontinue intrauterine device (IUD) use. Copper IUD (Cu IUD) users tend to experience increased menstrual bleeding, whereas levonorgestrel IUD (LNG IUD) users tend to have irregular menstruation. Medical therapies used to reduce heavy menstrual bleeding or pain associated with Cu and LNG IUD use include non-steroidal anti-inflammatory drugs (NSAIDs), anti-fibrinolytics and paracetamol. We analysed treatment and prevention interventions separately because the expected outcomes for treatment and prevention interventions differ. We did not combine different drug classes in the analysis as they have different mechanisms of action. This is an update of a review originally on NSAIDs. The review scope has been widened to include all interventions for treatment or prevention of heavy menstrual bleeding or pain associated with IUD use.